Alleviating the Burden of Depression: a Simulation Study on the Impact of Mental Health Services

Overview

Journal Epidemiol Psychiatr Sci

Publisher Cambridge University Press

Specialties Psychiatry
Public Health

Date 2024 Apr 2

PMID 38563188

Authors

M Wilhelm

S Bauer

J Feldhege

M Wolf

M Moessner

Affiliations

Soon will be listed here.

Abstract

Aims: Depressive disorders are ranked as the single leading cause of disability worldwide. Despite immense efforts, there is no evidence of a global reduction in the disease burden in recent decades. The aim of the study was to determine the public health impact of the current service system (status quo), to quantify its effects on the depression-related disease burden and to identify the most promising strategies for improving healthcare for depression on the population level.

Methods: A Markov model was developed to quantify the impact of current services for depression (including prevention, treatment and aftercare interventions) on the total disease burden and to investigate the potential of alternative scenarios (e.g., improved reach or improved treatment effectiveness). Parameter settings were derived from epidemiological information and treatment data from the literature. Based on the model parameters, 10,000,000 individual lives were simulated for each of the models, based on monthly transition rates between dichotomous health states (healthy vs. diseased). Outcome (depression-related disease burden) was operationalized as the proportion of months spent in depression.

Results: The current healthcare system alleviates about 9.5% (95% confidence interval [CI]: 9.2%-9.7%) of the total disease burden related to depression. Chronic cases cause the majority (83.2%) of depression-related burden. From a public health perspective, improving the reach of services holds the largest potential: Maximum dissemination of prevention (26.9%; CI: 26.7%-27.1%) and treatment (26.5%; CI: 26.3%-26.7%) would result in significant improvements on the population level.

Conclusions: The results confirm an urgent need for action in healthcare for depression. Extending the reach of services is not only more promising but also probably more achievable than increasing their effectiveness. Currently, the system fails to address the prevention and treatment of chronic cases. The large proportion of the disease burden associated with chronic courses highlights the need for improved treatment policies and clinical strategies for this group (e.g., disease management and adaptive or personalized interventions). The model complements the existing literature by providing a new perspective on the depression-related disease burden and the complex interactions between healthcare services and the lifetime course.

References

Cuijpers P, Karyotaki E, Weitz E, Andersson G, Hollon S, van Straten A . The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. J Affect Disord. 2014; 159:118-26. DOI: 10.1016/j.jad.2014.02.026. View

Legemaat A, Burger H, Geurtsen G, Brouwer M, Spinhoven P, Denys D . Effects up to 20-Year Follow-Up of Preventive Cognitive Therapy in Adults Remitted from Recurrent Depression: The DELTA Study. Psychother Psychosom. 2022; 92(1):55-64. DOI: 10.1159/000527906. View

Andrade L, Alonso J, Mneimneh Z, Wells J, Al-Hamzawi A, Borges G . Barriers to mental health treatment: results from the WHO World Mental Health surveys. Psychol Med. 2013; 44(6):1303-17. PMC: 4100460. DOI: 10.1017/S0033291713001943. View

Moriarty A, Meader N, Snell K, Riley R, Paton L, Dawson S . Predicting relapse or recurrence of depression: systematic review of prognostic models. Br J Psychiatry. 2022; 221(2):448-458. DOI: 10.1192/bjp.2021.218. View

Biesheuvel-Leliefeld K, Kok G, Bockting C, Cuijpers P, Hollon S, van Marwijk H . Effectiveness of psychological interventions in preventing recurrence of depressive disorder: meta-analysis and meta-regression. J Affect Disord. 2015; 174:400-10. DOI: 10.1016/j.jad.2014.12.016. View

Murray C, Vos T, Lozano R, Naghavi M, Flaxman A, Michaud C . Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2197-223. DOI: 10.1016/S0140-6736(12)61689-4. View

Herrman H, Patel V, Kieling C, Berk M, Buchweitz C, Cuijpers P . Time for united action on depression: a Lancet-World Psychiatric Association Commission. Lancet. 2022; 399(10328):957-1022. DOI: 10.1016/S0140-6736(21)02141-3. View

Kazdin A . Addressing the treatment gap: A key challenge for extending evidence-based psychosocial interventions. Behav Res Ther. 2017; 88:7-18. DOI: 10.1016/j.brat.2016.06.004. View

Jobst A, Brakemeier E, Buchheim A, Caspar F, Cuijpers P, Ebmeier K . European Psychiatric Association Guidance on psychotherapy in chronic depression across Europe. Eur Psychiatry. 2016; 33:18-36. DOI: 10.1016/j.eurpsy.2015.12.003. View

10.

Glasgow R, Lichtenstein E, Marcus A . Why don't we see more translation of health promotion research to practice? Rethinking the efficacy-to-effectiveness transition. Am J Public Health. 2003; 93(8):1261-7. PMC: 1447950. DOI: 10.2105/ajph.93.8.1261. View

11.

Bauer S, Okon E, Meermann R, Kordy H . Technology-enhanced maintenance of treatment gains in eating disorders: efficacy of an intervention delivered via text messaging. J Consult Clin Psychol. 2012; 80(4):700-6. DOI: 10.1037/a0028030. View

12.

Schneider F, Erhart M, Hewer W, Loeffler L, Jacobi F . Mortality and Medical Comorbidity in the Severely Mentally Ill. Dtsch Arztebl Int. 2019; 116(23-24):405-411. PMC: 6683445. DOI: 10.3238/arztebl.2019.0405. View

13.

Ormel J, Emmelkamp P . More Treatment, but Not Less Anxiety and Mood Disorders: Why? Seven Hypotheses and Their Evaluation. Psychother Psychosom. 2023; 92(2):73-80. PMC: 10273873. DOI: 10.1159/000528544. View

14.

Cohen Z, DeRubeis R . Treatment Selection in Depression. Annu Rev Clin Psychol. 2018; 14:209-236. DOI: 10.1146/annurev-clinpsy-050817-084746. View

15.

. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022; 9(2):137-150. PMC: 8776563. DOI: 10.1016/S2215-0366(21)00395-3. View

16.

. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390(10100):1211-1259. PMC: 5605509. DOI: 10.1016/S0140-6736(17)32154-2. View

17.

Ustun T, Ayuso-Mateos J, Chatterji S, Mathers C, Murray C . Global burden of depressive disorders in the year 2000. Br J Psychiatry. 2004; 184:386-92. DOI: 10.1192/bjp.184.5.386. View

18.

Busch M, Maske U, Ryl L, Schlack R, Hapke U . [Prevalence of depressive symptoms and diagnosed depression among adults in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013; 56(5-6):733-9. DOI: 10.1007/s00103-013-1688-3. View

19.

Bockting C, Hollon S, Jarrett R, Kuyken W, Dobson K . A lifetime approach to major depressive disorder: The contributions of psychological interventions in preventing relapse and recurrence. Clin Psychol Rev. 2015; 41:16-26. DOI: 10.1016/j.cpr.2015.02.003. View

20.

Kazdin A, Blase S . Rebooting Psychotherapy Research and Practice to Reduce the Burden of Mental Illness. Perspect Psychol Sci. 2015; 6(1):21-37. DOI: 10.1177/1745691610393527. View